Zhang, H., Saha, J., Byun, J., Schin, M., Lorenz, M., Kennedy, R. T., . . . Brosius, F. C. (2008). Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. American Physiological Society.
Styl ChicagoZhang, Hongyu, et al. Rosiglitazone Reduces Renal and Plasma Markers of Oxidative Injury and Reverses Urinary Metabolite Abnormalities in the Amelioration of Diabetic Nephropathy. American Physiological Society, 2008.
Citace podle MLAZhang, Hongyu, et al. Rosiglitazone Reduces Renal and Plasma Markers of Oxidative Injury and Reverses Urinary Metabolite Abnormalities in the Amelioration of Diabetic Nephropathy. American Physiological Society, 2008.